Pancreatic Carcinoma
Ghrelin promotes pancreatic adenocarcinoma cell proliferation and invasiveness
Published in Cancer Vaccine Week, November 10th, 2003
"Ghrelin, a newly described potent orexigenic peptide, may have therapeutic potential in patients with cachexia. We assessed whether pancreatic adenocarcinoma, commonly associated with marked cachexia, is a ghrelin-responsive malignancy," scientists in the United States report.
"Pancreatic adenocarcinoma cells were exposed to ghrelin (0-100 nM). Proliferation was determined by MTT assay. Ghrelin, ghrelin 1 a and 1b receptor expression, and Akt phosphorylation were assessed. The effects of ghrelin (its antagonist D-Lys-GHRP6, or the P13-K inhibitor Wortmannin) on cellular...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Vaccine Week
Source: Cancer Vaccine Week (2003-11-10)
More Articles from Cancer Vaccine Week
- Cancer Prevention
Promise, pitfalls of genotype versus gene products are discussed - Cellular Immunotherapy
European research project focused on optimizing a cancer vaccine - Leukemia
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells - Lung Cancer
Gene expression profiles in human non-small, small cell lung cancers analyzed - Anticancer Agents
History of anticancer drug development at the U.S. NCI reviewed - Anticancer Agents
Thymidylate synthase inhibitors may have promise as anticancer agents - More from this issue of Cancer Vaccine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
